AMPK and Beyond: Biology, Disease Mechanisms, and Therapeutic Opportunities


+ show speakers and program
Session 1. Sunday PM (7:30-8:30 PM) Keynote Lecture
Lewis Cantley (Harvard) (confirmed)
Session 2. Monday AM (8:30-noon). Advances in the Molecular Regulation of AMPK.
1. David Carling (Imperial College, London UK) (Confirmed).
2. Grahame Hardie (University of Dundee, UK) (Confirmed).
3. Bruce Kemp (St. Vincents Institute, Melbourne, Australia) (Confirmed).
Four Short presentations selected from applicants.
Session 3. Monday PM (1-4 PM). AMPK in cell growth and cancer.
1. Reuben Shaw (Salk Institute, San Diego) (Confirmed).
2. Craig Thompson (Memorial Sloan Kettering, NY) (Confirmed).
3. Russell Jones (McGill, Montreal) (Confirmed).
4. Phillip Dennis (NIH) (Confirmed).
Four Short presentations from applicants.
Poster session 1. (7:30-10 PM)
Young Investigator oral poster presentations (7:30 -8:30 PM)
Poster viewing (8:30-10 PM)
Session 4. Tuesday AM (8:30-noon). AMPK in vascular disease.
1. Ken Walsh (Boston University) (Confirmed).
2. Ming Zou (Oklahoma) (Confirmed).
3. Neil Ruderman (Boston University) (Confirmed)
Four Short presentations from applicants.
Session 5. Tuesday PM (1-4 PM). Novel Actions of AMPK and AMPK-related kinases.
1. Richard Roy (McGill, Montreal) (Confirmed).
2. Morris Birnbaum (U Penn) (Confirmed).
3. Shelley Berger (U Penn) (Confirmed)
Four Short presentations from submitted abstracts.
Poster session 2. Tuesday PM (7:30-10 PM)
Young Investigator oral poster presentations (7:30 -8:30 PM)
Poster viewing (8:30-10 PM)
Session 6. Wednesday AM (8:30-noon). LKB1-AMPK and Stem Cell Biology.
1. Nabeel Bardeesy (MGH, Boston) (Confirmed).
To be determined
Four Short presentations from submitted abstracts.
Session 7. Wednesday PM (1-4 PM). AMPK in diabetes and metabolism.
1. Greg Steinberg (McMaster University, Ontario) (Confirmed).
2. Laurie Goodyear (Joslin/Harvard, Boston) (Confirmed)
3. Kei Sakamoto (Nestle Institute, Lausanne,Switzerland) (Confirmed).
Four Short presentations from submitted abstracts.
Session 8. Thursday AM (8:30-noon). AMPK in myocardial disease.
1. Jason Dyck (Edmonton, Alberta) (Confirmed).
2. Rong Tian (University of Washington, Seattle) (Confirmed).
3. Lawrence Young (Yale, New Haven) (Confirmed).
Four Short presentations from submitted abstracts.
Session 9. Thursday PM (1-4 PM). AMPK and novel metabolic actions
1. Benoit Violet (Inserme, Paris) (Confirmed).
2. Barbara Kahn (Harvard, BIDMC, Boston) (Confirmed).
To be determined
Four Short presentations from submitted abstracts.
Session 10. Friday AM (8:30-noon). AMPK as a pharmacological target.
1. Juleen Zierath (Karolinska Institute, Stockholm): Novel approaches to activate AMPK via AMP metabolism
(Confirmed).
To be determined.
Four Short presentations from submitted abstracts.

7 Oct - 12 Oct 2012

Asilomar
United States of America
meeting website